
Company valuation, historical trends, and peer comparisons.
According to ANI Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.61B. This represents a change of -6.30% compared to the average of 1.72B of the last 4 quarters.
The mean historical Enterprise Value of ANI Pharmaceuticals, Inc. over the last ten years is 963.30M. The current 1.61B Enterprise Value has changed 67.01% with respect to the historical average. Over the past ten years (40 quarters), ANIP's Enterprise Value was at its highest in in the September 2025 quarter at 1.90B. The Enterprise Value was at its lowest in in the September 2020 quarter at 508.31M.
Average
963.30M
Median
873.04M
Minimum
525.26M
Maximum
1.62B
Discovering the peaks and valleys of ANI Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 66.82%
Maximum Annual Enterprise Value = 1.62B
Minimum Annual Increase = -38.47%
Minimum Annual Enterprise Value = 525.26M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 1.62B | 4.88% |
| 2024 | 1.55B | 46.35% |
| 2023 | 1.06B | 18.45% |
| 2022 | 892.43M | 16.28% |
| 2021 | 767.49M | 46.12% |
| 2020 | 525.26M | -38.47% |
| 2019 | 853.65M | 28.23% |
| 2018 | 665.71M | -27.21% |
| 2017 | 914.57M | 16.20% |
| 2016 | 787.07M | 66.82% |
The current Enterprise Value of ANI Pharmaceuticals, Inc. (ANIP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.41B
5-year avg
1.18B
10-year avg
963.30M
ANI Pharmaceuticals, Inc.’s Enterprise Value is less than Amphastar Pharmaceuticals, Inc. (1.61B), less than Bausch Health Companies Inc. (21.26B), less than Amneal Pharmaceuticals, Inc. (9.87B), less than Viatris Inc. (34.26B), less than Dr. Reddy's Laboratories Limited (1.18T), less than Teva Pharmaceutical Industries Limited (61.28B), greater than Harrow Health, Inc. (1.27B), greater than Collegium Pharmaceutical, Inc. (1.50B), greater than Lifecore Biomedical, Inc. (380.23M), greater than Evolus, Inc. (603.43M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.61B | $1.15B | |
| 21.26B | $3.03B | |
| 9.87B | $7.20B | |
| 34.26B | $21.52B | |
| 1.18T | $11.74B | |
| 61.28B | $48.06B | |
| 1.27B | $1.05B | |
| 1.50B | $769.16M | |
| 380.23M | $242.41M | |
| 603.43M | $483.80M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ANI Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ANI Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is ANI Pharmaceuticals, Inc.'s Enterprise Value?
What is the highest Enterprise Value for ANI Pharmaceuticals, Inc. (ANIP)?
What is the 3-year average Enterprise Value for ANI Pharmaceuticals, Inc. (ANIP)?
What is the 5-year average Enterprise Value for ANI Pharmaceuticals, Inc. (ANIP)?
How does the current Enterprise Value for ANI Pharmaceuticals, Inc. (ANIP) compare to its historical average?